Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Total Current Liabilities (2022 - 2025)

Praxis Precision Medicines has reported Total Current Liabilities over the past 4 years, most recently at $59.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $59.8 million for Q4 2025, up 59.18% from a year ago — trailing twelve months through Dec 2025 was $59.8 million (up 59.18% YoY), and the annual figure for FY2025 was $59.8 million, up 59.18%.
  • Total Current Liabilities for Q4 2025 was $59.8 million at Praxis Precision Medicines, up from $52.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PRAX hit a ceiling of $59.8 million in Q4 2025 and a floor of $15.7 million in Q4 2023.
  • Median Total Current Liabilities over the past 4 years was $33.6 million (2022), compared with a mean of $34.0 million.
  • Biggest five-year swings in Total Current Liabilities: tumbled 54.14% in 2023 and later soared 138.43% in 2024.
  • Praxis Precision Medicines' Total Current Liabilities stood at $34.3 million in 2022, then tumbled by 54.14% to $15.7 million in 2023, then soared by 138.43% to $37.6 million in 2024, then soared by 59.18% to $59.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $59.8 million (Q4 2025), $52.9 million (Q3 2025), and $48.6 million (Q2 2025) per Business Quant data.